Immunotherapy Vaccine Support
Until now, the vaccination approach for cancer has been carried out in the presence of the disease and not, as it occurs in prophylactic vaccination against infectious diseases, in healthy individuals. Presently, there are over 100 different types of cancer and about 7.6 million deaths per year worldwide.
IMMUNOTHERAPY: E+Peptide Cancer Vaccine
The human body is made up of trillions of living cells. These cells grow, divide, and die in an orderly fashion controlled by the DNA machinery within the cell. When DNA is damaged in a normal cell, the cell either repairs the damage of the DNA or the cell dies as a normal response. After the person becomes an adult, most cells divide only to replace worn-out or dying cells or to repair injuries. Cancer cell growth is different from normal cell growth and dying process. Presently, there are over 100 different types of cancer and about 7.6 million deaths per year worldwide.
HOW DOES CANCER OCCUR? Cancer is a series of diseases characterized by changes within the tissue cells. The human body living cells grow, divide, and die in an orderly fashion. Cancer cell growth is different from normal cell growth and dying process. In the presence of cancer disease, cancer cells continue to grow instead of dying and form new, abnormal cells with an abnormal DNA in the form of tumors. In addition, these cells can also invade other tissues, a property that normal cells do not possess. A cancerous cell manages to move throughout the body using the blood or lymph systems, making new blood vessels to feed itself and destroying healthy tissue in a process called invasion.
WHAT IS INMMUOTHERAPY? Tumor cells express antigens that can be recognized by the host’s immune system. When specific peptides are injected into cancer patients in an attempt to induce a systemic immune response they can originate a bounding of the tumor cells antigens that may result in the destruction of the cancer growing in different body tissues. This procedure is defined as active immunotherapy or vaccination in as much as the host’s immune system is either re-activated or re-stimulated to mount an effective, tumor-specific immune reaction that may ultimately lead to tumor regression.
Peptide-based active immunotherapy or vaccination against cancer diseases has made enormous progress and it is today an active and crucial area of investigation, holding a route for improving the clinical outcome in cancer patients.
PERSONALIZED E + PEPTIDE CANCER VACCINE: E+ peptide cancer vaccine has a specific combination of molecules that cause the cancer cells to start the process of dying. Specific protein and peptides are known to strengthen the immune system and polyphenols are widely known to be antimutagenic. A combination of these specific peptides and polyphenols has been quite effective at combating various types of cancer.
The advantages of using natural peptide-based active immunotherapy or vaccine include:
the a relatively easy assembly of these natural peptides
the simplicity of peptide administration in a clinical setting, and
the availability of in vitro assays that can assess patients’ immune progress or response to the vaccine.